Compare Lufax Holding Ltd (LU) vs Stryker Corporation (SYK) Price & Performance

Lufax Holding Ltd (LU) trades at $0.9467, down 3.54% on the day, reflecting persistent bearish technical signals and fundamental challenges. The company reported a net loss of $2.10 billion in 2025 with revenue declining to $21.7 billion in 2026, though it maintains a low P/S of 0.25 and P/B of 0.07. Recent corporate actions include a 10:1 reverse stock split effective October 23, 2026, aimed at compliance, while analyst consensus remains predominantly buy-rated despite earnings misses.

The outlook hinges on Lufax's ability to stabilize revenue and narrow losses amid regulatory pressures in China's consumer lending sector. Deep value arguments based on tangible book value and Ping An backing present a speculative opportunity, but execution risks and sustained negative cash flows pose significant threats to near-term shareholder value.

Stryker (SYK) trades at $276.97, up 0.57% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 64.98% gross margins and 14.43% net income margin, though recent Q1 2026 earnings missed expectations. Analyst consensus remains strongly bullish with 71% buy ratings and $368.11 price target, representing 33% upside potential. Recent news highlights ongoing legal investigations regarding manufacturing issues that caused an 8.8% stock drop in September 2026.

SYK presents a compelling investment case with robust fundamentals and strong analyst support, though near-term headwinds from legal scrutiny and manufacturing challenges create uncertainty. The stock's current valuation at 28.7 P/E appears reasonable given growth prospects, but investors should monitor Q3 2026 earnings results on October 29 for confirmation of business recovery from recent setbacks.